VCAN and neoplasm: In addition, a recent study (187) using bone marrow biopsies from 35 myeloma patients revealed a significant correlation of versikine accumulation with infiltration of CD8+ T cells supporting a model in which macrophages and regulatory DCs secrete tolerogenic versican which is subsequently degraded, generating versikine and further altering the immunosuppressive nature of the tumor microenvironment.